The “2025 Forum on Hong Kong and Macao Pharmaceutical Industry Development – Learning from Neighbours: Fostering an Ecosystem for Medical and Pharmaceutical Advancement” was held at the University of Macau (UM) recently.
The event was jointly organised by UM’s Centre for Pharmaceutical Regulatory Sciences (CPRS), Hong Kong Association of the Pharmaceutical Industry (HKAPI), Pharmaceutical Society of Macao, and the University of Hong Kong’s (HKU) Department of Pharmacology and Pharmacy, bringing together over 100 experts, scholars, government representatives and industry professionals from Hong Kong, Macau and mainland China to engage in in-depth discussions on key topics, including pharmaceutical policies and regulations in the Guangdong-Hong Kong-Macau Greater Bay Area (GBA), pharmacovigilance, clinical research and real-world data applications, as well as accessibility of innovative treatment options.
Furthermore, the forum aimed to promote collaborative innovation in the biopharmaceutical industry and support the development of a pharmaceutical ecosystem, according to UM.
Source and Photo: UM
COMMENTS